FRAXIPARINE
FRAXIPARINE
Dormant
DIN Number
02450623
Drug Class
Human
Market Date
Feb 5, 1998
Company
HC
Aspen Pharmacare Canada Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02450623
AIG Number0131662001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AB06 NADROPARIN
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
,
Intravenous
AHFS Classification20:12.04.16
Health Canada Classification
ACTIVE INGREDIENTS (1)
NADROPARIN CALCIUMActive
Strength: 9500 UNIT / ML
Monograph: NADROPARIN CALCIUM